About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is.

HeartBeam BEAT, announced the issuance of two new U.S. patents that strengthen its intellectual property portfolio and support the company’s expansion in remote cardiac diagnostics. The new ...

A new tool assesses coronary inflammation, which is often overlooked in measuring the risk of a heart attack. One doctor says this test could detect problems years in advance and save lives.

Fetal Heart Quantification (Fetal HQ) technology offers a non-invasive, highly accurate method for evaluating fetal heart morphology and function, making it a valuable tool for assessing the impact of ...

Advancements in heart transplant technology, focusing on machine perfusion's role in extending the time window for organ transport.

XVIVO's heart technology, including the XVIVO Heart Assist Transport device and a perfusion solution, provides an alternative to static ice storage.

XVIVO's heart technology, including the XVIVO Heart Assist Transport device and a perfusion solution, provides an alternative to static ice storage. The device pumps an oxygenated perfusion ...

The inception of machine perfusion, in which a device pumps a blood-like solution through the donor heart during transport, has significantly extended that window.

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors.

Why is the Demand for Perfusionists Increasing? 1. Rise in Heart Diseases: Due to unhealthy lifestyles and stress, cardiac diseases are becoming more common, increasing the need for surgeries.